World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
46
Citations
37214
World Ranking
18806
National Ranking
7681

Theocharis Panaretakis publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Theocharis Panaretakis sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 85 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Theocharis Panaretakis D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Theocharis Panaretakis sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 46 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Theocharis Panaretakis is a researcher affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research contributions primarily focus on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant emphasis on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research, and Cell Biology.

Their work covers a range of main topics including:

  • Prostate Cancer Treatment and Research
  • Bone health and treatments
  • Extracellular vesicles in disease
  • Cancer, Lipids, and Metabolism
  • Radiopharmaceutical Chemistry and Applications
  • RNA Research and Splicing
  • Hippo pathway signaling and YAP/TAZ

Theocharis Panaretakis has co-authored frequently with a group of collaborators, including:

  • Christopher J. Logothetis (20 publications)
  • Jian H. Song (16 publications)
  • Sue-Hwa Lin (14 publications)
  • Guoyu Yu (12 publications)
  • Paul G. Corn (11 publications)

Panaretakis's work has appeared in various scientific venues, most notably in:

  • Cancers (3 publications)
  • Prostate Cancer and Prostatic Diseases (3 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (3 publications)
  • Clinical Cancer Research (2 publications)
  • Oncogene (2 publications)

Recent papers authored or co-authored by Theocharis Panaretakis include:

  • "Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment," 2021, Clinical Cancer Research
  • "Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer," 2020, Cancers
  • "Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition," 2021, Oncogene
  • "Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone," 2021, Oncogene
  • "Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization," 2024, Proceedings of the National Academy of Sciences

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

    L. Galluzzi;J. M. Bravo-San Pedro;I. Vitale;S. A. Aaronson

  • Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

    Theocharis Panaretakis;Theocharis Panaretakis;Theocharis Panaretakis;Oliver Kepp;Oliver Kepp;Oliver Kepp;Ulf Brockmeier;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Molecular characteristics of immunogenic cancer cell death.

    A Tesniere;T Panaretakis;T Panaretakis;T Panaretakis;O Kepp;O Kepp;O Kepp;L Apetoh;L Apetoh;L Apetoh

  • Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis.

    M Obeid;M Obeid;M Obeid;T Panaretakis;T Panaretakis;T Panaretakis;N Joza;N Joza;N Joza;R Tufi;R Tufi;R Tufi

  • The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.

    T Panaretakis;N. Joza;N. Joza;N. Joza;Nazanine Modjtahedi;Nazanine Modjtahedi;Nazanine Modjtahedi;A Tesniere;A Tesniere;A Tesniere

  • Tumor cell-derived exosomes: a message in a bottle.

    Pedram Kharaziha;Sophia Ceder;Qiao Li;Theocharis Panaretakis

  • A novel community driven software for functional enrichment analysis of extracellular vesicles data

    Mohashin Pathan;Shivakumar Keerthikumar;David Chisanga;Riccardo Alessandro

  • Immunogenic cancer cell death: a key-lock paradigm.

    Antoine Tesniere;Lionel Apetoh;Lionel Apetoh;Lionel Apetoh;Francois Ghiringhelli;Francois Ghiringhelli;Francois Ghiringhelli;Nicholas Joza;Nicholas Joza;Nicholas Joza

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA

    Maria Berndtsson;Maria Hägg;Theocharis Panaretakis;Aleksandra Mandic Havelka

  • Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy

    E. Laane;K. Pokrovskaja Tamm;E. Buentke;K. Ito

  • Ecto‐calreticulin in immunogenic chemotherapy

    Michel Obeid;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Theocharis Panaretakis;Theocharis Panaretakis;Theocharis Panaretakis;Roberta Tufi;Roberta Tufi;Roberta Tufi

  • Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from “Silent” to Immunogenic

    Michel Obeid;Michel Obeid;Theocharis Panaretakis;Antoine Tesniere;Antoine Tesniere;Nick Joza;Nick Joza

  • Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin.

    Theocharis Panaretakis;Katja Pokrovskaja;Maria C. Shoshan;Dan Grandér

Frequent Co-Authors

Guido Kroemer
Guido Kroemer Université Paris Cité
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Antoine Tesniere
Antoine Tesniere Université Paris Cité
Boris Zhivotovsky
Boris Zhivotovsky Karolinska Institute
Dan Grandér
Dan Grandér Karolinska Institute
Lionel Apetoh
Lionel Apetoh Indiana University
Frank Madeo
Frank Madeo University of Graz
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
François Ghiringhelli
François Ghiringhelli Centre Georges François Leclerc
Beth Levine
Beth Levine The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students who major in Biology or Biochemistry in the USA have the opportunity to pursue a variety of advanced online degrees and careers in healthcare and research. For those interested in management roles within the medical sector, consider exploring the top cahme accredited mha programs. These programs prepare graduates for leadership positions in healthcare administration.

If your career interests are in advanced nursing but you are looking for programs with flexible clinical requirements, you may want to research dnp program no clinical options. These degrees enable nurses to reach the highest levels in their field with more accessible online study paths.

For students passionate about research or policy, an advanced degree like a phd in healthcare management can open doors to academia, consultancy, or executive roles in healthcare systems.

Alternatively, if you are drawn to pharmaceutical sciences, there are excellent pharm d online programs that can prepare graduates for careers as licensed pharmacists or researchers.

Whether you aim for clinical leadership, research, or specialized practice, these online degree options provide flexible pathways for Biology and Biochemistry graduates to advance their careers in the healthcare sector.

Best Scientists Citing Theocharis Panaretakis

Trending Scientists

Recently Published Articles